Hemmelgarn Brenda R
Department of Medicine, Division ofNephrology, University of Calgary, Calgary, Alberta, Canada.
Clin Invest Med. 2006 Dec;29(6):383-7.
Aboriginal people in Canada have an increased prevalence of ESRD, are more likely to initiate renal-replacement therapy on hemodialysis, and are much less likely to receive a kidney transplant compared to non-Aboriginals. Once established on dialysis quality of care and survival is similar for Aboriginal and non-Aboriginal people with ESRD. Understanding issues central to the health and outcomes of Aboriginal patients with ESRD, and documenting potential inequities in care, is essential to guide strategies to develop a new model for delivery of services for management of ESRD among Aboriginal people. Two areas in particular require further investigation for Aboriginal people with ESRD, namely the need to further investigate potential barriers to kidney transplantation, and reasons for lower rates of peritoneal dialysis as a form of renal replacement therapy. Research in this area will enable targeted interventions to be developed in partnership with the Aboriginal communities, with a goal to increase the health outcomes and quality of life for Aboriginal people with ESRD.
与非原住民相比，加拿大原住民的终末期肾病（ESRD）患病率更高，更有可能开始接受血液透析的肾脏替代治疗，而接受肾脏移植的可能性则要小得多。一旦开始透析，原住民和非原住民ESRD患者的护理质量和生存率相似。了解原住民ESRD患者健康和治疗结果的核心问题，并记录护理中潜在的不平等现象，对于制定为原住民ESRD管理提供服务的新模式的策略至关重要。对于原住民ESRD患者，有两个领域尤其需要进一步研究，即需要进一步调查肾脏移植的潜在障碍，以及腹膜透析作为肾脏替代治疗形式的使用率较低的原因。该领域的研究将有助于与原住民社区合作制定有针对性的干预措施，目标是改善原住民ESRD患者的健康结果和生活质量。
